Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.95 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.95 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | MAP2K1 | Q02750 | 7/20 | 0.33 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.32 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.32 |
| ▸ | IARS2 | Q9NSE4 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodixanol SCHEMBL8845042 | 1.00 | LMNA (1.00) | LMNACYP2C19HIF1AEGFRSRC | |
| Iodixanol SCHEMBL21546 | 1.00 | LMNA (1.00) | LMNACYP2C19HIF1AEGFRSRC | |
| Iodixanol SCHEMBL22645199 | 0.99 | LMNA (0.97) | LMNACYP2C19HIF1AEGFRSRC | |
| Iohexol SCHEMBL8844889 | 0.97 | CYP2C19 (1.00) | LMNACYP2C19HIF1AEGFRSRC | |
| Iohexol SCHEMBL31722694 | 0.97 | CYP2C19 (1.00) | LMNACYP2C19HIF1AEGFRSRC | |
| Iohexol SCHEMBL37920 | 0.97 | CYP2C19 (1.00) | LMNACYP2C19HIF1AEGFRSRC | |
| Iohexol SCHEMBL26501 | 0.97 | CYP2C19 (1.00) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL12589793 | 0.96 | LMNA (0.93) | LMNACYP2C19HIF1AEGFRSRC | |
| Iohexol SCHEMBL8711982 | 0.96 | CYP2C19 (0.97) | LMNACYP2C19HIF1AEGFRSRC | |
| Iohexol SCHEMBL22719758 | 0.95 | CYP2C19 (0.95) | LMNACYP2C19HIF1AEGFRSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2380 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704924-A1 | RADIONUCLIDE-LOADED NANOPARTICLES FOR FOCAL TISSUE ABLATION | TRANSLATIONAL AND FUNDAMENTAL TECHNOLOGIES INSTITUTE LLC (US) | 2026-03-11 | — | — | EP | claimed |
| EP-3893913-B1 | TRANSFERRIN RECEPTOR TARGETING PEPTIDES | FRED HUTCHINSON CANCER CENTER (US) | 2025-03-26 | — | — | EP | claimed |
| US-20250043251-A1 | METHOD FOR FURTHER UPSCALING THE LARGE-SCALE PRODUCTION OF THE ONCOLYTIC H-1 PROTOPARVOVIRUS (H-1PV) USING A CARRIER-BASED PRODUCTION PROCESS COMBINED WITH AN OPTIMIZED CELL CULTURE MEDIUM | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS (DE) | 2025-02-06 | — | — | US | claimed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | claimed |
| WO-2024226199-A1 | RADIONUCLIDE-LOADED NANOPARTICLES FOR FOCAL TISSUE ABLATION | RAIKA MEDICAL IMAGING INC. (US) | 2024-10-31 | — | — | WO | claimed |
| US-20240350684-A1 | RADIONUCLIDE-LOADED NANOPARTICLES FOR FOCAL TISSUE ABLATION | TRANSLATIONAL AND FUNDAMENTAL TECHNOLOGIES INSTITUTE LLC | 2024-10-24 | — | — | US | claimed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | claimed |
| EP-4408985-A1 | METHOD FOR FURTHER UPSCALING THE LARGE-SCALE PRODUCTION OF THE ONCOLYTIC H-1 PROTOPARVOVIRUS (H-1PV) USING A CARRIER-BASED PRODUCTION PROCESS COMBINED WITH AN OPTIMIZED CELL CULTURE MEDIUM | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2024-08-07 | — | — | EP | claimed |
| WO-2023052429-A1 | METHOD FOR FURTHER UPSCALING THE LARGE-SCALE PRODUCTION OF THE ONCOLYTIC H-1 PROTOPARVOVIRUS (H-1PV) USING A CARRIER-BASED PRODUCTION PROCESS COMBINED WITH AN OPTIMIZED CELL CULTURE MEDIUM | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2023-04-06 | — | — | WO | claimed |
| US-20220169992-A1 | OPTIMIZED PARVOVIRUS H-1 PRODUCTION | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2022-06-02 | — | — | US | claimed |
| CN-1161324-C | Yellow polymorphic forms of 5-amino-2, 4, 6-triiodo-N, N' -bis (2, 3-dihydroxypropyl) isophthalamide | ��Īɳķ������˾ | 2004-08-11 | — | — | CN | claimed |
| CN-1494435-A | Preparation for preventing restenosis | �����ڶ���ϣ | 2004-05-05 | — | — | CN | claimed |
| EP-1372737-A2 | PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS | Speck, Ulrich (DE) | 2004-01-02 | — | — | EP | claimed |
| CN-1129566-C | Method for crystallization of sterically hindered compounds | NYCOMBED IMAGING AS (NO) | 2003-12-03 | — | — | CN | claimed |
| CN-1092182-C | Process for preparation of contrast agent | NYCOMED IMAGING AS (NO) | 2002-10-09 | — | — | CN | claimed |
| WO-2002076509-A2 | PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS | SPECK ULRICH (DE) | 2002-10-03 | — | — | WO | claimed |
| CN-1340042-A | Preparation of iodixanol | NYCOMED IMAGING AS (NO) | 2002-03-13 | — | — | CN | claimed |
| CN-1273574-A | Process for crystallisation of sterically hindered compound | NYCOMBED IMAGING AS (NO) | 2000-11-15 | — | — | CN | claimed |
| CN-1257479-A | Yellow polymorph of 5-amino-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)-isophthalamide | NYCOMED IMAGING AS (NO) | 2000-06-21 | — | — | CN | claimed |
| CN-1228762-A | Process for preparation of contrast agent | NYCOMED IMAGING AS (NO) | 1999-09-15 | — | — | CN | claimed |